Glenn H Nussdorf insider trades
Open-market stock purchases and sales by Glenn H Nussdorf, Director at Organogenesis Holdings Inc, from SEC Form 4 filings since Apr 18, 2012.
Track record: 0% of 10 scored buys are up 5% or more since purchase, averaging -75%.